The conversion of Calquence’s accelerated approval in mantle cell lymphoma comes a day before the drug was listed among the 15 products to be subject to IRA-prescripted price negotiations for Medicare this year.
AstraZeneca Gets Full FDA Approval for CMS-Selected Lymphoma Treatment Read More »
Drugmakers will have until the end of February to decide whether they want to participate in the second round of Medicare negotiations or not. CMS has until June 1 to send an initial offer for the adjusted prices.
Novo’s Ozempic, Wegovy Targeted in Second Round of IRA Drug Price Negotiations Read More »
The shape of AI regulation will be uncertain under the Trump administration this year, while healthcare companies will continue bolstering cyber defenses to withstand increasing attacks, experts say.
BD invested $10 million last year to increase manufacturing capacity. The recent expansion has created more than 200 jobs.
BD expands syringe, needle production capacity in Nebraska and Connecticut Read More »
Novartis is locked in a legal back-and-forth with MSN Pharma over alleged patent infringement of its heart failure drug Entresto.
Novartis Scrambles to Squelch Copycats as Generics Gain Ground Read More »
Boehringer Ingelheim’s trio of late-stage schizophrenia failures on Thursday came a day after the Department of Health and Human Services hit back on the pharma’s legal challenge to the IRA’s drug price negotiation program.
Boehringer Suffers Phase III Schizophrenia Fail, Legal Parry by HHS Read More »
The Phase III CodeBreaK 300 study returned disappointing overall survival data for Lumakras plus Vectibix in metastatic colorectal cancer, but in its approval announcement, the FDA pointed to significant improvements in progression-free survival, calling it the “major efficacy outcome” of the trial.
Looking Beyond Obesity, Amgen Wins Colorectal Cancer Expansion for Lumakras Read More »
Tristemente, los incendios de este mes en el condado de Los Ángeles, de California, Estados Unidos, han alcanzado tal magnitud que ha sido posible verlos claramente desde el espacio. El astronauta Don Pettit de la NASA tomó desde la estación Espacial Internacional esta …
En un estudio reciente, se ha profundizado en las galaxias con el tamaño y brillo más pequeños de entre todas las conocidas. En estas galaxias enanas y de luminosidad ultradébil, la formación de nuevas estrellas cesó hace muchos millones de años, por …
Desde que las dos naves de la misión Proba-3 fueron lanzadas juntas al espacio el 5 de diciembre de 2024, han permanecido unidas. Eso ha cambiado el 14 de enero de 2025 (o 15 de enero dependiendo de la zona horaria). Siguiendo el plan previsto, estas naves de la Agencia Espacial Euro …
Proba-3 se divide en dos satélites en el espacio Read More »
